Recently, Zhang et al. [32], demonstrated that VEGF expression rate in mesenchymal CTCs was significantly higher than that of epithelial CTCs, which suggested that VEGF may be correlated with tumor malignancy “and probably with the resistance”. The gene discussed is VEGFA; the disease is neoplasm.